Abstract #0036
Hybrid PET/MRI for Evaluation of Nodal Disease in Lymphoma
Laura Heacock 1 , Joseph Weissbrot 1 , Roy Raad 1 , Naomi Campbell 1 , Kent Friedman 1 , Christian Geppert 2 , and Hersh Chandarana 1
1
Radiology, NYU Langone Medical
Center, New York, NY, United States,
2
Siemens
Medical Solutions, New York, NY, United States
PET/CT is routinely performed in evaluation of
disease burden in patients with Non Hodgkin
Lymphoma (NHL). MRI with diffusion weighted
imaging (DWI) has shown promise. In this study
we compared the accuracy of morphologic MRI
including DWI and PET/MR in detection of nodal
disease with PET/CT as a reference. Our results
suggest that PET/MR outperformed DWI for
assessment of nodal disease and had sensitivity
similar to PET/CT. Furthermore there was
excellent correlation in SUVmax as measured with
PET/MR and PET/CT. Thus PET/MR may be a viable
option to PET/CT in evaluation of patients with
lymphoma.
This abstract and the presentation materials are available to members only;
a login is required.
Join Here
